Handouts for Patients:
Handouts for patients can be found here.
Resources:
- Relke N, Chornenki NLJ, Sholzberg M. Tranexamic acid evidence and controversies: An illustrated review. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12546. doi: 10.1002/rth2.12546. PMID: 34278187; PMCID: PMC8279901. https://pubmed.ncbi.nlm.nih.gov/34278187/
- Zia A, Rajpurkar M. Challenges of diagnosing and managing the adolescent with heavy menstrual bleeding. Thromb Res. 2016 Jul;143:91-100. doi: 10.1016/j.thromres.2016.05.001. Epub 2016 May 3. PMID: 27208978. https://pubmed.ncbi.nlm.nih.gov/27208978/
- Philipp CS, Faiz A, Heit JA, et al. Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol. 2011;204(3):209.e1-209.e2097. doi:10.1016/j.ajog.2010.10.897
- American Academy of Pediatrics Committee on Adolescence; American College of Obstetricians and Gynecologists Committee on Adolescent Health Care; Diaz A, Laufer MR, Breech LL. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics. 2006 Nov;118(5):2245-50. doi: 10.1542/peds.2006-2481. PMID: 17079600. https://pubmed.ncbi.nlm.nih.gov/17079600/
- Paula D. James, Nathan T. Connell, Barbara Ameer, Jorge Di Paola, Jeroen Eikenboom, Nicolas Giraud, Sandra Haberichter, Vicki Jacobs-Pratt, Barbara Konkle, Claire McLintock, Simon McRae, Robert R. Montgomery, James S. O’Donnell, Nikole Scappe, Robert Sidonio, Veronica H. Flood, Nedaa Husainat, Mohamad A. Kalot, Reem A. Mustafa; ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 2021; 5 (1): 280–300. doi: https://doi.org/10.1182/bloodadvances.2020003265
- Tengborn L, Blombäck M, Berntorp E. Tranexamic acid–an old drug still going strong and making a revival. Thromb Res. 2015 Feb;135(2):231-42. doi: 10.1016/j.thromres.2014.11.012. Epub 2014 Nov 20. PMID: 25559460. https://pubmed.ncbi.nlm.nih.gov/25559460/
- Zia, A, Kouides, P, Khodyakov, D, et al. Standardizing care to manage bleeding disorders in adolescents with heavy menses—A joint project from the ISTH pediatric/neonatal and women’s health SSCs. J Thromb Haemost. 2020; 18: 2759– 2774. https://doi.org/10.1111/jth.14974
- Rosen MW, Weyand AC, Pennesi CM et al. Adolescents Presenting to the Emergency Department with Heavy Menstrual Bleeding. J . J Pediatr Adolesc Gynecol; 2020; 33: 139-143
- Johnson S, Lang A, Sturm M et al. iron deficiency without anemia: a common yet underdiagnosed diagnosis in young women with heavy menstrual bleeding. J Pediatr Adolesc Gynecol 2016; 29- 628
- Kulkarni R. Improving care and treatment options for women and girls with bleeding disorders. Eur J Haematol. 2015;95 Suppl 81:2-10
- Boender J, Kruip MJ, Leebeek FW. A diagnostic approach to mild bleeding disorders. J Thromb Haemost. 2016 Aug;14(8):1507-16.
- Developing a multidisciplinary Young Women’s Blood Disorders Program: a single-centre approach with guidance for other centres. Zia A, Lau M, Journeycake J et al . 2016 Mar;22(2):199-207
13. Acharya, S.S., (2023, April 20). Inherited abnormalities of fibrinogen.
14. American College of Obstetricians and Gynecologist, Committee on Adolescent Health Care,
Number 785 (2019). ACOG committee opinion: Bleeding Disorders in Adolescents (Reaffirmed
15. Casola, A.R., Luber, K., Riley, A.H., Medley, L. (2022). Menstrual health: Taking action against period poverty. AJPH Opinions, Ideas, &Practice, 112(3), p. 374. https://ajph.
16. Centers for Disease Control and Prevention. (2022). Bleeding Disorders in Women. Retrieved fromhttps://www.cdc.gov/
17. Liberty, A., Samuelson, B., Matteson, K., Edelman, A., Colwill,A. (2023). Menstrual technology innovations and implications for heavy menstrual bleeding. Current Commentary,
18. United States Food and Drug Administration. (2023). Fibrinogen concentrates(human) approval dates.
